ESMO - Eur. Oncology· @myESMO · X·· 2 days agoScore45
Body
#ESMO26: Phase II data suggest selected patients with localised gastro-oesophageal adenocarcinoma (#GEA) may benefit from a dostarlimab watch-and-wait strategy that can achieve good responses without surgery
🔗 https://ow.ly/H76250ZZiMQ
#InsightsbyESMO #GICancers
847 views · 3 likes · 1 repost · 0 replies
Conference abstracts
2877ROmatched by Rapid oral 1: Gastrointestinal tumour, upper digestive
Watch-and-wait (W&W) strategy for dostarlimab in localized deficient dMMR/MSI-H gastroesophageal adenocarcinoma (GEA): Results from the first interim analysis of the GERCOR-GONO DEWI phase II study
https://esmocongress.esmo.orgSource: ESMO - Eur. Oncology · x.com